Overview: Free Carnitine TestIntroduction: The Free Carnitine Test measures free carnitine levels to diagnose carnitine deficiency, causing muscle weakness or fatigue, helping guide supplementation or treatment. Affecting 1 in 100,000 people, carnitine deficiency poses diagnostic challenges due to metabolic variability. Following 2023 American College of Medical Genetics (ACMG) guidelines, it uses LC-MS/MS for high accuracy, supporting biochemistry screening. This test is vital for diagnosis, intervention planning, and improving outcomes in metabolism.
Other Names: Carnitine Level Test, Free Carnitine Assay.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic reliability.
Historical Milestone: Carnitine testing began in the 1970s with research by Engel, who linked it to deficiency. LC-MS/MS advancements in the 2000s by Agilent improved detection, surpassing earlier enzymatic methods.
Purpose: Measures free carnitine levels to diagnose deficiency, guides carnitine supplementation, and evaluates patients with muscle weakness, aiming to prevent complications.
Test Parameters: Free carnitine levels
Pretest Condition: Fasting preferred to reflect baseline levels. Collect plasma or serum. Report history of metabolic issues.
Specimen: Plasma (NaHep, 2-4 mL), Serum (SST, 2-5 mL); 2 mL plasma in Na Heparin tube. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: 1 month
Medical History: Document muscle weakness or fatigue. Include current medications or dietary habits.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., cardiomyopathy), and sample collection risks.
Procedural Considerations: Uses LC-MS/MS to measure carnitine, requiring labs with mass spectrometers. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample hemolysis or non-fasting status can skew results. Medications may alter levels, requiring correlation.
Clinical Significance: Low carnitine confirms deficiency, guiding therapy. Early treatment might prevent complications, while untreated cases lead to worsening. Normal levels may require follow-up.
Specialist Consultation: Consult a metabolic specialist for interpretation.
Additional Supporting Tests: Total carnitine, acylcarnitine profile, or genetic panel to confirm diagnosis.
Test Limitations: Non-specific for cause; correlation with symptoms needed. Fasting variability may affect accuracy.
References: ACMG Guidelines, 2023; Journal of Clinical Investigation, Engel AG, 2022.
